Gi‐eun Rhie - Infectious Diseases

Author Information

Gi-eun Rhie is affiliated with the Division of High-risk Pathogens, Center for Laboratory Control of Infectious Diseases at the Korea Centers for Disease Control and Prevention, located in Cheongju, South Korea. Rhie's work primarily focuses on infectious diseases, with a particular emphasis on genomic epidemiology and pathogen characterization.

Research Contributions

Gi-eun Rhie's research encompasses a broad array of topics within the field of infectious diseases. Rhie has contributed significantly to the understanding of genomic epidemiology, as seen in the study of SARS-CoV-2 spread and control in the Republic of Korea. Additional research highlights include the characterization of pathogens such as Clostridium botulinum and Bacillus anthracis, as well as the development of vaccine candidates against anthrax and smallpox. Rhie's work also includes early laboratory preparedness and response strategies to novel outbreaks, exemplified by the response to the COVID-19 pandemic's onset.

Aliases

Gi-eun Rhie has been published under several aliases, including G E Rhie, Gi-eun Rhie, G.-e. Rhie, G. E. Rhie, Gi Eun Rhie, and G Rhie. These variations may appear across different publications and databases.

Publication and Citation Metrics

Total Citation Count	2282
h-index	23
Total Paper Count	92

Publications:

Draft Genome Sequence of Francisella tularensis subsp. holarctica Strain H0001, Isolated from a Tularemia Patient in the Republic of Korea

DOI: 10.1128/mra.00719-21

Year: 2022

Genomic epidemiology reveals the reduction of the introduction and spread of SARS-CoV-2 after implementing control strategies in Republic of Korea, 2020

DOI: 10.1093/ve/veab077

Year: 2021

Corrigendum to: Genomic epidemiology reveals the reduction of the introduction and spread of SARS-CoV-2 after implementing control strategies in Republic of Korea, 2020

DOI: 10.1093/ve/veab088

Year: 2021

Early Laboratory Preparedness of the Korea Disease Control and Prevention Agency and Response to Unknown Pneumonia Outbreak from Wuhan, China, in January 2020

DOI: 10.3343/alm.2021.41.6.532

Year: 2021

Genetic Characterization of Clostridium botulinum Isolated from the First Case of Infant Botulism in Korea

DOI: 10.3343/alm.2021.41.5.489

Year: 2021

A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate

DOI: 10.1186/s12865-021-00414-y

Year: 2021

Construction of a bivalent vaccine against anthrax and smallpox using the attenuated vaccinia virus KVAC103

DOI: 10.1186/s12866-021-02121-5

Year: 2021

Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea

DOI: 10.1002/jmv.27499

Year: 2021

Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020

DOI: 10.24171/j.phrp.2021.12.1.06

Year: 2021

Evaluation of the protective efficacy of recombinant protective antigen vaccine (GC1109)-immunized human sera using passive immunization in a mouse model.

DOI: 10.1016/j.vaccine.2019.12.048

Year: 2020

What is Flaviviridae?

What is the Prognosis for Individuals with HSV?

What are the Modes of Transmission?

How Effective Are Insecticides?

Why Are Regular Health Check-Ups Important?

What are Infectious Agents?

What Diseases Require Quarantine?

What is Fatty Acid Biosynthesis?

Who Should Receive Antiviral Treatment?

What are the Challenges in Protein Targeting?

Partnered Content Networks

Relevant Topics